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Abstract
Although the significance of lysine modifications of core histones for regulating gene expression is widely appreciated, the
mechanisms by which these modifications are incorporated at specific regulatory elements during cellular differentiation
remains largely unknown. In our previous studies, we have shown that in developing myoblasts the Msx1 homeoprotein
represses gene expression by influencing the modification status of chromatin at its target genes. We now show that
genomic binding by Msx1 promotes enrichment of the H3K9me2 mark on repressed target genes via recruitment of G9a
histone methyltransferase, the enzyme responsible for catalyzing this histone mark. Interaction of Msx1 with G9a is
mediated via the homeodomain and is required for transcriptional repression and regulation of cellular differentiation, as
well as enrichment of the H3K9me2 mark in proximity to Msx1 binding sites on repressed target genes in myoblast cells as
well as the developing limb. We propose that regulation of chromatin status by Msx1 recruitment of G9a and other histone
modifying enzymes to regulatory regions of target genes represents an important means of regulating the gene expression
during development.
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Introduction
Cellular differentiation during development involves the coor-
dinated change in expression of many thousands of genes in
appropriate spatial and temporal contexts. A principal mechanism
by which this occurs is through modification of the core histones
(H3, H4, H2A, and H2B) that comprise nucleosomes, which are
the fundamental units of chromatin. There are at least 8 distinct
types of histone modifications, of which the most critical for
transcriptional repression is lysine methylation, the enzymatic
transfer of one or more methyl groups from the donor S-
Adenosylmethionine (SAM) onto the e-nitrogen of lysine [1,2].
Genome-wide mapping studies using ChIP-Chip and ChIP-Seq
have shown that di-methylation of histone H3 at lysine 9
(H3K9me2) is widely found at repressed genes during develop-
ment and in embryonic stem cells [3,4] while perturbation of the
H3K9me2 mark results in a profound change in the repression
status [5,6]. The relevant histone lysine methyltransferase enzyme
is G9a, a member of the highly conserved SET domain family,
which, as part of a complex containing GLP, is responsible for
catalyzing the H3K9me2 mark [7–11]. Thus, mutant mice lacking
G9a are seriously impaired in the H3K9me2 mark and display
embryonic lethality reflecting the consequences of global pertur-
bation of gene repression [12]. Notably, the H3K9me2 mark,
which is associated with transcriptional repression (regulated
inhibition of gene expression), is distinct from tri-methylation of
H3K9, which is associated with transcriptional silencing (perma-
nent inhibition of gene expression), and is mediated by another
SET domain protein, Suv39H1 [10,13–15].
The homeoprotein family comprises one of the major classes of
sequence-specific DNA binding proteins, which regulate gene
expression and cellular differentiation during development.
Among its members is the Msx1 homeoprotein, which is expressed
in diverse spatial and temporal domains during development but
restricted to cells that have not yet begun to differentiate [16,17].
In the myogenic lineage, for example, Msx1 is expressed in
myogenic precursors during development as well as in adult
myogenic satellite cells (i.e., stem cells), but not in differentiated
myotubes [18–20]. Forced expression of Msx1 in myoblast cells
inhibits their differentiation [21,22], which is mediated by the
actions of Msx1 as a transcriptional repressor. In particular, Msx1
represses MyoD, which is a principal regulator of myogenic
differentiation, by binding to a key regulatory element, the Core
Enhancer Region (CER) [20,22–25] that regulates the timing of
MyoD expression in vivo [26].
Previously, we have shown that regulation of myoblast
differentiation and repression of MyoD expression by Msx1 is
correlated with increased repressor marks at the CER of MyoD
[25], which include increased tri-methylation of H3K27
(H3K27me3) [23]. We now show that in myoblasts as well as
the developing limb genomic binding by the Msx1 homeoprotein
promotes enrichment of the H3K9me2 mark on repressed target
genes via recruitment of the G9a histone methyltransferase, the
enzyme responsible for catalyzing this histone mark [7–11].
Interaction of Msx1 with G9a is mediated via the homeodomain
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cellular differentiation, as well as enrichment of the H3K9me2
mark in proximity to Msx1 binding sites on repressed target genes.
Based on our findings on the recruitment of the H3K9me2 mark,
in conjunction with our recently published findings regarding the
role of Msx1 in recruiting H3K27me3 to target genes [23], we
describe four distinct categories of Msx1 target genes that are
distinguished by differential recruitment of the relevant histone
methyltransferases. Our findings suggest that an important means
of regulating gene expression during development involves the
differential recruitment of histone modifying enzymes to regula-
tory regions of target genes to influence chromatin status.
Results
Msx1 is Associated with H3K9me2 and Binds to G9a
Following from our previous study showing that repression of
MyoD by Msx1 is correlated with increased repressor marks at a
key regulatory element, the CER [25] and associated with
increased tri-methylation of H3K27 (H3K27me3) [23], we looked
more generally at how Msx1 may influence the modification status
of core histones on target genes in myoblast cells. We found that
Msx1 associates specifically with H3K9me2 but not H3K9me3 in
co-immunoprecipitation assays using proteins immunopurified
from C2C12 cells (Figure 1A). Notably, the H3K9me2 mark,
which is associated with repression, is distinct from tri-methylation
of H3K9, which is associated with transcriptional silencing [10,13–
15].
Considering that Msx1 is associated with H3K9me2, we next
asked whether Msx1 interacts with G9a, which is the enzyme that
is responsible for this methyl mark. We found that both exogenous
Msx1 expressed in C2C12 myoblast cells and endogenous Msx1
expressed in the developing limb interacted strongly with G9a,
regardless of whether co-immunoprecipitation assays were done
using antibodies to pull down Msx1 or G9a (Figure 1B and 1C).
Msx1 also associated with GLP (Figure 1C), which forms a
complex with G9a, but it did not interact with Suv39H1
(Figure 1C), which is responsible for tri-methylation of H3K9
and associated with gene silencing rather than repression [14].
Msx1 has multiple functional domains that mediate interactions
with protein partners, DNA binding, transcriptional repression
and/or sub-nuclear location [23–25]. Analyses of truncated Msx1
proteins lacking these various functional domains revealed that the
homeodomain of Msx1 is the primary domain required for its
interaction with G9a (Figure 1D and 1E). In particular, a
truncated Msx1 protein lacking the homeodomain [Msx1(1–
172)] did not interact with G9a, while various other truncated
Msx1 proteins that contained the homeodomain but lacked for
example domains required for repression Msx1(139–303);
Msx1(1–239); and Msx1(1–271)] interacted with G9a, albeit with
varying degrees of efficacy (Figure 1D and 1E). Notably the
homeodomain is required for DNA binding by Msx1 but also
mediates interactions of Msx1 with other protein partners
[16,20,23,27]. Taken together, these findings indicate that Msx1
associates with G9a histone methyltransferase via the homeodo-
main, although the important caveat to these studies in the
possible influence of these altered domains on the structure of the
protein overall.
Msx1 Genomic Binding Associates with Enrichment of
the H3K9me2 Repressive Mark
Having established that Msx1 interacts with G9a, we next asked
whether genomic binding by Msx1 is associated with increased
levels of H3K9me2 on its repressed target genes in myoblast cells.
In particular, we examined the status of H3K9me2 as a
consequence of Msx1 expression at several sites on MyoD as well
as several other myogenic regulators that are repressed by Msx1
[23], namely Myf5, Angpt1, Myc, Six1, and Snai2 [28–34] (Figure 2A
and 2B). Interestingly, we found that binding by Msx1 resulted in
increased levels of H3K9me2 on certain but not all of these
genomic binding sites. For example, Msx1 binding was associated
with increased H3K9me2 on the CER regions of MyoD (MyoD-4;
P=4.4610
25) and the 258 kb site of Myf5 (Myf5-2;
P=2.4610
27), both of which are known homeoprotein regulatory
elements that control expression of these respective genes in vivo
[26,33,34]. In contrast, H3K9me2 was not increased at the Msx1
binding sites of other target genes, such as Snai2 (Figure 2B).
Interestingly, for the target gene, Six1, where Msx1 binds to two
sites (Six1–3 and Six1–6), only one of the sites (Six1–6) was
enriched for H3K9me2 (Figure 2B); notably, we have found that
the other site (Six1–3) displays an Msx1-dependent enrichment for
an alternative methyl mark, H3K27me3 [23]. Furthermore, the
Msx1-dependent enrichment of H3K9me2 was well correlated
with recruitment of G9a binding to these sites (Figure 2C). In
particular, ChIP-qPCR analyses revealed that G9a binding was
significantly enriched at relevant Msx1 binding sites, including the
CER (MyoD-4; P=0.001) and the 258 kb site of Myf5 (Myf5-2;
P=5.8610
25), but not on its binding site on Snai2, which is also
not enriched for H3K9me2 (Figure 2C, compare with Figure 2B).
In the case of Six1, G9a was bound at only at the Msx1 site that
was enriched for H3K9me2 (Six1–6; Figure 2B).
To investigate whether these findings were also relevant for
endogenous Msx1 in vivo, we performed ChIP analysis using limb
from wild-type or Msx mutant embryos. We found that the levels
of H3K9me2 were significantly reduced in the Msx mutant versus
wild-type limb at the MyoD CER (MyoD-4; P=1.7610
25) and
the 258 kb region of Myf5 (Myf5-2; P=4.9610
25) but not at
Snai2-1 (Figure 3). Notably, similar to our findings in the myoblast
cells, levels of H3K9me2 on the Six1 gene were significantly
reduced in the Msx mutant versus wild-type limb at the Six1–6,
but not at Six1–3 (Figure 3). Taken together, these data suggest
that, for the endogenous protein in vivo as well as the exogenous
protein in myoblast cells, Msx1 recruits G9a to selected genomic
targets where it promotes enrichment of the H3K9me2 repressive
mark in the vicinity of its binding.
Association of Msx1 with G9a is Required for Regulation
of Myoblast Differentiation
We next investigated the consequences of Msx1 association with
G9a for regulation of myogenic differentiation by evaluating the
consequences of G9a knock-down in C2C12 myoblast cells. We
used two independent G9a siRNAs and verified their efficacy and
specificity in C2C12 cells using q-PCR to evaluate G9a mRNA
levels and Western blotting to detect levels of G9a protein or levels
of histone marks (Figure 4A-C); for most assays, only one siRNA is
shown. The consequences of G9a knock-down for regulation of
differentiation by Msx1 were evaluated by the appearance of
myotubes and by Western blot detection of markers of terminal
muscle differentiation, namely myosin heavy chain (MHC) and
Myogenin (Figure 4D and 4E). Without exogenous Msx1
expression, C2C12 cells (Vector) were differentiated by 3 days
after induction regardless of whether they expressed the control or
G9a siRNA as evident by myotubes formation (Figure 4D, top
panel) and expression of MHC and Myogenin (Figure 4E, left
panel). However, as we have shown previously [21,24,25], Msx1
completely abrogates differentiation of C2C12 cells, as evident by
the absence of myotubes (Figure 4D, left bottom panel) and lack of
expression of MHC and Myogenin (Figure 4E, right panel). In
Msx1 Recruits G9a to Target Genes
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on myoblast differentiation, as evident from the appearance of
myotubes (Figure 4D, right bottom panel) and expression of MHC
and Myogenin (Figure 4E, right panel).
We quantified the differentiation status of the C2C12 cells at 2
days after induction of differentiation using an antibody for MHC
to detect the MHC+ cells and determine the myogenic index [35].
In vector cells, depletion of G9a resulted in a higher myogenic
differentiation compared with those expressing the control siRNA
(Figure 4F and 4G), consistent with a role G9a in myogenic
differentiation as reported recently [35]. However, in Msx1-
expressing cells, depletion of G9a restored the myogenic differen-
tiation nearly the levels without Msx1 (Figure 4F and 4G). These
findings demonstrate that G9a is essential for Msx1 to inhibit
myogenic differentiation in these myoblast cells.
Association of Msx1 with G9a is Required for
Transcriptional Repression
We next investigated the consequences of Msx1 association with
G9a for transcriptional repression following knock-down of G9a in
C2C12 myoblast cells. Depletion of G9a significantly reduced
Msx1 binding to genomic sites of repressed genes in myoblast cells
in ChIP assays, as exemplified for the CER (MyoD-4;
P=1.1610
27) and the 258 kb element of Myf5 (Myf5-2;
P=3.8610
24) (Figure 5A). Interestingly however, analyses of
Msx1 binding in vitro in gel shift assays showed that G9a knock-
down did not inhibit binding by Msx1 to these genomic target
sequences, namely the MyoD CER (MyoD-4) or Myf5-1
(Figure 5B). Notably, we have previously shown a distinction
between binding of Msx1 in vitro and its ability to bind with target
sequences in vivo, which is dependent on interactions with its
protein partners in vivo [23,24]. Thus, while G9a may not directly
affect the affinity of Msx1 for its binding sites (Figure 5B),
considering that depletion of G9a impaired in Msx1 ability to
interact with genomic binding sites in vivo (Figure 5A), G9a may
affect the ability of Msx1 to access authentic target sites in
myoblast cells.
Notably, the diminished binding of Msx1 to repressed genes in
myoblast cells as a consequence of G9a knock-down was
accompanied by a partial abrogation of repression of its target
Figure 1. Msx1 binds to G9a/GLP via the homeodomain and the C-terminal region. (A) Co-immunoprecipitation assays were done using
C2C12 cell protein extracts expressing Flag-Msx1 and immunoprecipitated with anti-Flag followed by immunoblotting for the indicated histone
marks. (B) 293T cells were transfected with the indicated expression plasmids. Proteins were immunoprecipitated with Flag antibodies and
immunoblotted with anti-Flag or Anti-Myc, as indicated. (C) (Left) C2C12 cell protein extracts expressing Flag-Msx1 were immunoprecipitated with
anti-Flag following by immunoblotting with antibodies to detect the indicated proteins. (Right) Limb extracts (11.5 dpc) expressing endogenous Msx1
were immunoprecipitated with anti-Msx1 antibody (4F11) following by immunoblotting with antibodies to detect the indicated proteins. (D)
Truncated Msx1 proteins expressed in 293T cells were immunopurified with anti-Flag followed by immunoblotting to detect G9a. Shown is the
quantitative analyses of G9a, normalize to G9a input and Msx1 input. In each immunoprecipitation assays, 1 mg of protein was used and input was
1% of the total protein. (E) Schematic representation of Msx1 and truncated derivatives showing a summary of data.
doi:10.1371/journal.pone.0037647.g001
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37647Figure 2. Msx1 genomic binding associates with enrichment of the H3K9me2 repressive mark in myoblast cells. (A) Diagram of six
Msx1 repressed target genes [23] showing the positions of Msx1 binding sites and known regulatory regions as well as their overlap; also shown is a
negative control site. DRR: Distal Regulatory Region. (B) ChIP-qPCR analyses showing the relative levels of H3K9me2 at Msx1 genomic binding sites in
C2C12 cells. ChIP data are expressed as relative enrichment of H3K9me2 normalized to input in C2C12 cells expressing or lacking Msx1. (Inset) ChIP
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of G9a in Msx1-expressing but not the cells without Msx1 (Vector)
(Figure 5C and 5D). The notable exception was Myf5, which was
increased in expression at the protein and mRNA levels in the
vector cells (lacking exogenous Msx1) following G9a knock-down
(Figure 5C and 5D). Although depletion of G9a in C2C12 cells
does not affect MyoD mRNA and protein levels (see Figure 5C
and 5D), it may inhibit its transcriptional activity, in turn leading
to up-regulation of Myf5 (Figure 5C and 5D, top panel), which is
consistent with a recent study showing that G9a interacts with
MyoD to constrain its transcriptional activity [35]. Finally,
following G9a knock-down in Msx1 expressing C2C12 cells, we
observed a significant reduction in the H3K9me2 mark, but not
the H3K9me3 mark, on Msx1 target genomic binding sites such as
CER (MyoD-4; P=7.8610
25) and the 258 kb region of Myf5
(Myf5-2, P=4.2610
24), as well as on the genes that are regulated
by G9a but not Msx1 such as MageA2, Major satellite, and Wfdc15a,
but not on a gene (GAPDH) that is not regulated by either Msx1 or
G9a (Figure 6A–H) [6,12]. Taken together, these findings
demonstrate that the interaction of Msx1 with G9a in myoblast
cells is essential for Msx1 to bind and repress target genes in cells
and for enrichment of the H3K9me2 repressive mark at specific
genomic binding sites.
The G9a associated with Redistribution of H3K27me3 by
Msx1 to Genomic Sites
Finally, since we have shown previously that repression by Msx1
is correlated with increased tri-methylation of H3K27
(H3K27me3) [23], we asked whether Msx1 association with G9a
affected the H3K27me3 mark on target genes. Since depletion of
G9a did not reduce the total level of H3K27me3 (Figure 4C), we
asked whether Msx1 association with G9a is required for the
Msx1-dependent redistribution of H3K27me3 on its genomic
bound sites. In the presence of control siRNA, Msx1 promotes
enrichment of the H3K27me3 repressive mark on its genomic
sites, such as MyoD-2, MyoD-4, Myf5-1 and Myf5-2 [23] (Figure 7A).
In contrast, genes that were neither bound nor regulated by Msx1,
such as Dkk1, En2, and Irx1 had reduced levels of H3K27me3 in
Msx1-expressing C2C12 cells with control siRNA [23] (Figure 7B).
However in Msx1 expressing C2C12 cells, knock-down of G9a
dramatically reduced the H3K27me3 mark on Msx1 genomic sites
(Figure 7A), while it resulted in reversed the H3K27me3 reduction
at Dkk1, En2, and Irx1 associated with exogenous Msx1 expression
(Figure 7B). Furthermore, since the association of Msx1 with the
nuclear periphery is associated with the redistribution of the
H3K27me3 mark [23], we asked whether G9a affects the sub-
nuclear location of Msx1. Strikingly, we found that depletion of
G9a dramatically interrupted Msx1 nuclear periphery localization
(Figure 7C). These findings suggest that Msx1 association with
G9a contributes to the Msx1-dependent redistribution of
H3K27me3 genomic bound sites by affecting the nuclear
periphery localization of Msx1.
Discussion
The impact of Msx1 on cellular differentiation during develop-
ment is dependent on its ability to repress the expression of
regulatory genes in specific cellular contexts, such as occurs for
MyoD in cells of the myogenic lineage [22,24,25]. Our current
data expressed as fold enrichment of H3K9me2 in C2C12 cells expressing Msx1 versus the control cells lacking Msx1 (and normalized to input). (C)
ChIP-qPCR assays were done using C2C12 cells expressing Flag-Msx1 or a control vector to evaluate binding of G9a to the indicated Msx1 target
sequences. ChIP data are expressed as relative enrichment of G9a binding normalized to input in C2C12 cells expressing or lacking Msx1. (Inset) ChIP
data are expressed as fold enrichment of G9a binding in C2C12 cells expressing Msx1 versus the control cells lacking Msx1 (and normalized to input).
In B and C, the * indicate the following: ***P,0.0001, **P,0.001, *P,0.01.
doi:10.1371/journal.pone.0037647.g002
Figure 3. Msx1 genomic binding associated with enrichment of the H3K9me2 repressive mark in the developing limb. ChIP-qPCR
analyses show relative levels of H3K9me2 at Msx1 genomic binding sites in Msx1; Msx2 conditional mutant versus wild-type limb (13.5 dpc). ChIP data
are expressed as relative enrichment of the H3K9me2 mark normalized to input. (inset) ChIP data expressed as fold enrichment in wild-type
embryonic limb versus Msx1; Msx2 conditional mutant embryonic limb (and normalized to input). The * indicate the following: ***P,0.0001,
**P,0.001, *P,0.01.
doi:10.1371/journal.pone.0037647.g003
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ability to directly influence the methylation status of nucleosomes
on selected regulatory elements to which it is bound in myoblast
cells (Figure 8). Our findings further indicate that this reflects, in
part, recruitment of the G9a histone methyltransferase to these
regulatory sites, which in turn promotes methylation of core
histones in the vicinity of Msx1 binding (Figure 8; Table S1).
Notably, recruitment of the G9a histone methyltransferase by
Msx1 is mediated via the homeodomain, which is the defining
feature of this family of sequence specific developmental regulators
[16,20,22,24,25]. Implicit in this observation is that other
homeoproteins may also recruit methyltransferase enzymes to
target genes as a means of regulating their expression.
However, G9a is not recruited to all Msx1 target genes.
Moreover, Msx1 also interacts via the homeodomain with another
histone methyltransferase, Ezh2, which leads to enrichment of its
respective histone mark, namely H3K27me3, on certain target
genes (Figure 8; Table S1) [23]. In fact, we can identify 4 scenarios
in which Msx1 differentially recruits histone methyltransferases to
target genes to regulate their expression. In particular, in the first
case Msx1 recruits both H3K9me2 and H3K27me3 repressive
marks at the same binding site, as is the case for target genes, such
as, MyoD, Myf5, Myc, and Angpt1 [18,26,28,31,33,34]. In the
second scenario, Msx1 recruits both H3K9me2 and H3K27me3
repressive marks to target genes, but at the different sites. For
instance, Msx1 binds to two sites on Six1 (Six1–3 and Six1–6), one
of the sites (Six1–6) is enriched for H3K9me2 while the other site
(Six1–3) displays an Msx1-dependent enrichment for H3K27me3
[23,29,30]. In the third case, Msx1 only recruits the H3K27me3
mark, as in the case for Snai2, Met, and Id3 [32,36,37]. The final
Figure 4. Association of Msx1 with G9a is required for regulation of myoblast differentiation. (A) Quantitative PCR to determine the level
of G9a mRNA following knock-down by siRNA, mRNAs were prepared 48 hours after transfection with the indicated siRNA. (B) Western blot assay for
efficiency of G9a knock-down, C2C12 cells were transfected with the indicated siRNA, extracts prepared 72 hours after transfection and analyzed by
western blotting for the indicated proteins. (C) Western blot assay for histone marks. C2C12 cells were transfected with the indicated siRNA, extracts
prepared 72 hours after transfection and analyzed by western blotting for the indicated histone marks. (D) Differentiation assay of C2C12 cells
expressing (+) or lacking (-) Msx1 along with the control or G9a siRNA. Micrographs of C2C12 cells show the absence of myotubes in Msx1-expressing
cells but not in cells also expressing the G9a siRNA on Day 3 after differentiation. (E) Western blots analyses of markers of terminal muscle
differentiation, MHC and Myogenin on Day 3 after differentiation. (F) Immunofluorescence assays done on Day 2 after differentiation as detected
using antibody for MHC and the nuclear marker TOPRO3. The scale bars represent 50 mm. (G) Quantitative analyses of myogenic index on Day 2 after
differentiation. The percentage of MHC+ cells in vector cells with control siRNA was given a value of 100%. In A and G, the * indicate the following:
***P,0.0001, **P,0.001, *P,0.01.
doi:10.1371/journal.pone.0037647.g004
Msx1 Recruits G9a to Target Genes
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37647Figure 5. Association of Msx1 with G9a is required for transcriptional repression. (A) ChIP-qPCR analyses showing relative Msx1 binding in
C2C12 cells expressing or lacking Msx1 as well as a control or G9a siRNA. ChIP data are expressed as fold enrichment of Msx1 binding in C2C12 cells
expressing Msx1 versus control cells lacking Msx1. (B) Gel shift analyses were done using nuclear extracts from C2C12 cells expressing Flag-Msx1 as
well as the control or G9a siRNA with DNA sequences corresponding to the MyoD CER (MyoD-4) and Myf5-1. The * indicate the protein-DNA binding
bands, the arrowhead indicates the free probes. (C) Expression levels of Msx1 target genes in Msx1-expressing or lacking Msx1 C2C12 cells also
expressing the control or G9a siRNA. Data are expressed as the fold change of mRNA relative to that of the control siRNA cells. The * indicate the
following: ***P,0.0001, **P,0.001, *P,0.01. (D) Western blots analyses showing levels of MyoD and Myf5 protein following by G9a knock-down in
Msx1-expressing or lacking Msx1 C2C12 cells.
doi:10.1371/journal.pone.0037647.g005
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for either H3K9me2 or H3K27me3, such as Clcn3 and Fgf7
[38,39].
Implicit in this description is the important but yet unanswered
question regarding how Msx1 recruits multiple histone methyl-
transferases to distinct target genes in specific spatial contexts.
Therefore, Msx1 may interact with multiple histone methyltrans-
ferases to influence the expression of target gene in dynamic spatial
contexts. Furthermore, since the region of methyltransferases
recruitment is the homeodomain, a conserved motif, our findings
raise the possibility that other homeoproteins may also function by
promoting the recruitment of histone modifying enzymes to target
genes. Thus, our findings demonstrate a novel means by which
homeoproteins can regulate gene expression during development
by interacting with histone modifying enzymes to directly
influence the chromatin status of target genes.
Materials and Methods
Plasmids
Most of the expression plasmids used in this study has been
described previously [24,25]. As indicated, pcDNA3 expression
plasmids were used for transient transfection and pLZRS-IRES-
GFP plasmids for retroviral gene transfer. Flag-tagged G9a was
generated using PCR amplification and cloned into BamH I –
Xho I sites of pcDNA3. The complete sequences of all PCR-
amplified constructs were confirmed.
Cell Culture Analyses
Cell culture studies were done using human 293T cells
(ATCC) or mouse C2C12 myoblast cells (ATCC). Cells were
maintained in DMEM supplemented with 10% fetal bovine
serum in humidified atmosphere with 5% CO2 at 37uC. For
myoblast differentiation assays, undifferentiated C2C12 cells
were grown in media containing 10% fetal bovine serum, and
differentiation was induced by shifting cells to media containing
2% horse serum [21,24,25]. Transient transfection was per-
formed using Lipofectamine 2000 reagent (Invitrogen). For
retroviral gene transfer, replication-defective retroviruses were
made in ecotropic Phoenix retroviral packaging cells (ATCC) by
transfection of the relevant pLZRS-IRES-GFP plasmid deriva-
tives using Lipofectamine 2000 reagent (Invitrogen). C2C12
myoblast cells were seeded 1 day before infection and infected
with viral supernatants for two consecutive days. For siRNA,
C2C12 cells were first infected with viruses expressing Msx1 or
the empty vector and then transfected with siRNA against G9a
Figure 6. Binding analyses of H3K9 methyl marks in G9a knock-down cells. ChIP-qPCR assays were done using C2C12 cells expressing Flag-
Msx1 as well as the control or G9a siRNA using anti-H3K9me2 or anti-H3K9me3 or control IgG, as indicated. ChIP data are expressed as relative
enrichment normalized to input in control siRNA cells or G9a knock-down cells.
doi:10.1371/journal.pone.0037647.g006
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gen) according to the manufacturer’s recommendations. For the
control siRNA using SilencerH Select negative control #1 siRNA
(Ambion). The sequences of G9a siRNA (Ambion) used in these
studies are provided in Table S2. Quantitative analyses of
differentiation of the G9a knock-down C2C12 cells were done
by immunofluorescence staining with MHC antibody (see the
below). Quantitative analyses of myogenic index were preformed
on Day 2 after differentiation. Myogenic index calculation was
done as described in [35]. At least 3 independent assays were
done per variable, counting a minimum of 500 cells per
variable for each independent assay. The percentage of MHC+
cells in vector cells with control siRNA was given a value of
100%.
Analyses of Msx1 Mutant Embryos
All experiments using animals were performed according to
protocols approved by the Institutional Animal Care and Use
Committee at Columbia University Medical Center. The Msx1
mutant were performed using a compound Msx1; Msx2
conditional allele [40] crossed to a ubiquitously-expressed
tamoxifen-inducible Rosa26
CreERT2 allele [41] to generate mice




deletion was induced by delivery of tamoxifen in corn oil
(2 mg/40 grams; Sigma-Aldrich) by oral gavage at embryonic
day 9.5 (9.5 days post-coitum, dpc); targeted deletion in the tissue
of interest (i.e., the limb) was confirmed by PCR analyses. The
analyses described herein focused on mid-gestation embryos,
from days 10.5 to 13.5 dpc, at which developmental stages the
limb buds are maturing and Msx1 expression is robust in the
limb mesenchyme [16,42]. Embryos were collected from timed
mating with noon on the day of the plug considered to be
Figure 7. G9a is required for Msx1-induced redistribution of H3K27me3 by Msx1 and localization of Msx1 at the nuclear periphery
in C2C12 myoblasts. (A) ChIP-qPCR analyses of H3K27me3 mark on Msx1 target genes in C2C12 cells lacking Msx1 or expressing exogenous Msx1
also expressing the control or G9a siRNA. ChIP data are expressed as relative enrichment of the H3K27me3 mark normalized to input. (B) ChIP-qPCR
analyses of H3K27me3 mark on genes not bound by Msx1 in C2C12 cells lacking Msx1 or expressing exogenous Msx1 also expressing the control or
G9a siRNA. ChIP data are expressed as relative enrichment of the H3K27me3 mark normalized to input. (C) Immunofluorescence assays were done on
C2C12 cells expressing exogenous Msx1 together with the G9a siRNA or a control siRNA and detected using antibodies for Msx1 or by detection of
the nuclear marker TOPRO3. Quantitative analyses of nuclear localization for Msx1 using ImageJ show representative data from 3 independent assays,
each counting a minimum of 20 cells per variable. The scale bars represent 5 mm.
doi:10.1371/journal.pone.0037647.g007
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DNA. For ChIP assays, freshly dissected limbs were collected in
PBS with protease inhibitor cocktail and disrupted using a
Polytron homogenizer. Tissue extracts were cross-linked with
1% formaldehyde for 30 minutes at room temperature, cross-
linking was stopped with 0.1 M Glycine, and cross-linked limb
was collected by centrifugation and processed for ChIP-qPCR
analyses as below.
Real-time PCR for Gene Expression
Real-time PCR was done using RNA isolated from C2C12 cells,
using Trizol reagent (Invitrogen), and purified using an RNeasy kit
(Qiagen). First strand cDNA was synthesized using SuperScript III
kit (Invitrogen) and quantitative real-time PCR was performed
using SYBR green reagent (Qiagen) in the Realplex
2 machine
(Eppendorf). Expression values were normalized to GAPDH.A t
least three independent experiments were performed for each
gene. The average values are given as the mean 6 SD. The primer
sequences for real-time PCR using in this study were provided in
Table S2.
Chromatin Immunoprecipitation (ChIP)
ChIP analysis was performed as described previously [24,25].
Briefly, C2C12 cells expressing or lacking Msx1 and/or siRNA for
G9a were cross-linked using 1% formaldehyde and genomic DNA
was sonicated and then the relevant protein-DNA complexes were
isolated by immunoprecipitation. ChIP analysis from limb, the
cross-linked limb tissue was sonicated and then the relevant
protein-DNA complexes were isolated by immunoprecipitation.
The antibodies were used for ChIP assays were provided in Table
S3. Quantitative real-time PCR was performed in triplicate using
SYBR green reagent (Qiagen) using a Realplex
2 machine
(Eppendorf). At least three independent experiments were done
for each assay. Primer sequences for ChIP-qPCR analyses were
provide in Table S2.
Immunoprecipitation and Western Blotting Analyses
For Western blotting, C2C12 cells were lysed in RIPA buffer
and proteins were analyzed using ECL plus Western Blotting
Detection (GE Healthcare) by indicated antibodies (Table S3). For
immunoprecipitation assays, C2C12 cells were lysed in RIPA
buffer and proteins were immunoprecipitated by addition of
antibodies [24,25]. Where indicated, nuclear extracts from
embryonic limbs were obtained by homogenization in hypotonic
buffer (20 mM HEPES [pH 7.4], 5 mM NaCl, 1 mM EDTA,
10 mM MgCl2, 1 mM DTT, and protease inhibitor cocktail) to
isolate nuclei followed by extraction of nuclear proteins in buffer
BC1000 (25 mM HEPES [pH 7.9], 10% glycerol, 0.2 mM
EDTA, 1000 mM KCl, protease inhibitor cocktail, and PMSF)
containing 0.1% NP40. The samples were then sonicated,
centrifuged at 16,000 g, and then dialyzed against BC200
(25 mM HEPES [pH 7.9], 10% glycerol, 0.2 mM EDTA,
200 mM KCl, protease inhibitor cocktail, and PMSF) containing
0.1% NP40. Immunoprecipitations were done in BC200 contain-
ing 0.1% NP40 and immunoprecipitated proteins were analyzed
using ECL plus Western Blotting Detection (GE Healthcare). The
antibodies were used for immunoprecipitation and immunopre-
cipitation Western blotting were provided in Table S3.
Gel Shift Assay
The probe of MyoD CER (MyoD-4) and Myf5-1 were
generated fragment from ChIP DNA by using PCR method with
ChIP-qPCR primer sets (Table S2). For nuclear extracts, the
C2C12 cells were homogenized in hypotonic buffer. The nuclei
were incubated for 10 min on ice and then pelleted by
centrifugation at 8,000 g, and resuspended in BC1000 buffer
containing 0.1% NP40 to extract nuclear proteins. The samples
were then sonicated, centrifuged at 16,000 g, and dialyzed against
BC200 containing 0.1% NP40. The binding reaction was perform
in 16 binding buffer (10 mM Tris-HCl pH 7.5, 5 mM NaCl,
0.7 mM MgCl2, 0.1 mM EDTA, 5% Glycerol, 0.05% NP-40, and
50 mg/ml BSA, 2.5 mM DTT) with 2 mg poly d(I-C), 50 ng probe,
and 5 mg of nuclear protein from C2C12 cells expressing Flag-
Msx1 as well as the control or G9a siRNA in total volume of 20 ml.
Binding was done at room temperate for 20 min. Protein-DNA
binding complexes were resolved by electrophoresis. After finished
running the gel, the gel was stained by SYBR Safe DNA gel stain
(Invitrogen) and the digital imagines were captured by CCD
camera.
Figure 8. Working model. As described in the text, we have
proposed that binding of the Msx1 homeoprotein to specific target
genes brings G9a and/or Ezh2 to the regulatory regions of these genes
to influence histone modifications. According G9a and Ezh2 bound
status, the Msx1 bound and down-regulated target genes were
categorized in 4 categories. (A) Category I, Msx1 brings G9a and Ezh2
to the same site on target genes. (B) Category II, Msx1 brings G9a and
Ezh2 to the same target genes but at different sites. (C) Category III,
Msx1 only brings Ezh2 to the Msx1 bound site on target genes. (D)
Category IV, Msx1 do not brings ether G9a or Ezh2 to the target genes,
but Msx1 may brings other factors to Msx1 bound site to repress target
genes expression.
doi:10.1371/journal.pone.0037647.g008
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Immunofluorescence analyses were done as described previous-
ly [23]. Briefly C2C12 cells seeded on 1-well BD Falcon
TM
CultureSlide and transfected with the indicated Msx1 plasmids
and, where indicated, also with the siRNA for G9a. Cells were
fixed in 4% PFA in PBS with 1% sucrose and permeabilized by
incubation in an isotonic solution, 0.5% Triton X-100 (10%
sucrose, 50 mM NaCl, 6 mM MgCl2, 20 mM HEPES [pH 7.2],
0.5% Triton X-100). After blocking with 1% BSA (bovine serum
albumin) in PBS, cells were incubated for 1.5 hours at room
temperature with primary antibodies. Following incubation with
primary antibodies, samples were washed in PBS containing 0.1%
Tween 20 followed by incubation for 1 hour with TOPRO 3 and
AlexaFluor 488 and/or AlexaFluor 555 secondary antibodies
(Molecular Probes). Immunofluorescence staining was visualized
using a Leica TCS SP5 inverted confocal microscope equipped
with argon/krypton and helium/neon lasers capable of excitation
wavelengths 488, 555, and 642 nm. Details of primary antibodies
are provided in Table S3. The Msx1 sub-nuclear localization was
quantified using ImageJ (http://rsb.info.nih.gov/ij/) [43]. A line
was drawn from the nuclear periphery to the nuclear center, and
along this line, the fluorescence intensity was recorded; the pixel
values versus radial position were used to generate the quantitative
plot.
Statistical Analysis
At least three independent experiments were performed for
each assay. The average values of the parallel experiments are
given as the mean 6 SD. Comparison of differences among the
groups was carried out by Student’s t-test. Significance was defined
as p,0.01. (***p,0.0001, **p,0.001, *p,0.01).
Supporting Information
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(DOCX)
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